Related Experiment Videos
[Hemolytic anemias due to enzymopathies]
1INSERM U 91, hôpital Henri-Mondor, Créteil.
La Revue Du Praticien
|June 1, 1993
Summary
Inherited red blood cell enzymopathies, often linked to glycolysis, cause hemolytic anemias. Gene therapy offers future treatment, while prenatal diagnosis aids severe cases.
Area of Science:
- Hematology
- Biochemistry
- Genetics
Context:
- Enzymopathies are inherited disorders affecting red blood cell metabolism.
- Deficiencies in red blood cell enzymes disrupt energy production, particularly glycolysis.
- Most enzymopathies are autosomal recessive, with exceptions like G6PD and PGK being X-linked.
Purpose:
- To review inherited red blood cell enzymopathies causing hemolytic anemias.
- To discuss the metabolic consequences of enzyme deficiencies in red blood cells.
- To explore current and future therapeutic and diagnostic approaches.
Summary:
- Inherited enzymopathies leading to hemolytic anemias result from reduced enzyme synthesis or function, primarily affecting red blood cell glycolysis.
- These genetic disorders are typically autosomal recessive, except for glucose-6-phosphate dehydrogenase and phosphoglycerate kinase deficiencies, which are X-chromosome-linked.
- While gene therapy represents a promising future treatment, prenatal diagnosis is an option for severe presentations.
Impact:
- Highlights the significance of red blood cell metabolism in inherited hemolytic anemias.
- Underscores the potential of gene therapy for treating these genetic disorders.
- Emphasizes the importance of prenatal diagnosis for managing severe cases of enzymopathies.